Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection
dc.contributor.author | Lodi, Sara | |
dc.contributor.author | Fisher, Martin | |
dc.contributor.author | Phillips, Andrew | |
dc.contributor.author | Luca, Andrea de | |
dc.contributor.author | Ghosn, Jade | |
dc.contributor.author | Malyuta, Ruslan | |
dc.contributor.author | Zangerle, Robert | |
dc.contributor.author | Moreno, Santiago | |
dc.contributor.author | Vanhems, Philippe | |
dc.contributor.author | Boufassa, Faroudy | |
dc.contributor.author | Guiguet, Marguerite | |
dc.contributor.author | Porter, Kholoud | |
dc.date.accessioned | 2018-05-07T17:53:31Z | |
dc.date.available | 2018-05-07T17:53:31Z | |
dc.date.created | 2014-09-12 | |
dc.date.issued | 2013-11-14 | none |
dc.identifier.other | http://edoc.rki.de/oa/articles/reEqgnmEH9IY/PDF/23vSmaILcrBMo.pdf | |
dc.identifier.uri | http://edoc.rki.de/176904/1948 | |
dc.description.abstract | Background: The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking. Methods: CASCADE patients with HIV test interval | eng |
dc.language.iso | eng | |
dc.publisher | Robert Koch-Institut, Infektionsepidemiologie | |
dc.subject | Humans | eng |
dc.subject | HIV-1 | eng |
dc.subject | Female | eng |
dc.subject | Male | eng |
dc.subject | CD4 Lymphocyte Count | eng |
dc.subject | Biological Markers/blood | eng |
dc.subject | Disease-Free Survival | eng |
dc.subject | HIV Seropositivity/blood | eng |
dc.subject | HIV Seropositivity/drug therapy | eng |
dc.subject | HIV Seropositivity/immunology | eng |
dc.subject | HIV Seropositivity/mortality | eng |
dc.subject | HIV Seropositivity/pathology | eng |
dc.subject | Models Biological | eng |
dc.subject | Severity of Illness Index | eng |
dc.subject | Survival Rate | eng |
dc.subject.ddc | 610 Medizin | |
dc.title | Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection | |
dc.type | periodicalPart | |
dc.identifier.urn | urn:nbn:de:0257-10037421 | |
dc.identifier.doi | 10.1371/journal.pone.0078642 | |
dc.identifier.doi | http://dx.doi.org/10.25646/1873 | |
local.edoc.container-title | PLoS ONE | |
local.edoc.container-text | Lodi S, Fisher M, Phillips A, De Luca A, Ghosn J, et al. (2013) Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection. PLoS ONE 8(11): e78642. | |
local.edoc.fp-subtype | Artikel | |
local.edoc.type-name | Zeitschriftenartikel | |
local.edoc.container-type | periodical | |
local.edoc.container-type-name | Zeitschrift | |
local.edoc.container-url | http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0078642 | |
local.edoc.container-publisher-name | Public Library of Science | |
local.edoc.container-volume | 8 | |
local.edoc.container-issue | 11 | |
local.edoc.container-year | 2013 |